Andreas Baumbach
Latest contributions
PCR Gulf Valves 2025 Closing Ceremony
30 Sep 2025 – From PCR Gulf Valves 2025
Join the PCR Gulf Valves 2025 Closing Ceremony to reflect on the advancements and highlights of this year’s sessions dedicated to valvular interventions. This event marks the culmination of comprehensive educational activities, fostering collaboration and innovation in valvular heart disease management within the Gulf region.
Intervening in aortic regurgitation: are we finally there?
30 Sep 2025 – From PCR Gulf Valves 2025
Explore the evolving landscape of transcatheter treatment for aortic regurgitation in this informative session. Understand the anatomical and clinical criteria essential for selecting candidates for transcatheter therapy, review the latest device options supported by real-world and investigational data, and learn to navigate procedural challenges with advanced...
Facilitated TAVI in bicuspid aortic valve disease - LIVE Case
30 Sep 2025 – From PCR Gulf Valves 2025
Gain valuable insights into performing facilitated transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valve disease. This session covers the approach to challenging femoral access, unique anatomical considerations, and critical decision-making in device selection, sizing, and implantation techniques, demonstrated through a LIVE educational case...
Myval transcatheter heart valve series - Align for the future with novel design, data and daily clinical experience
29 Sep 2025 – From PCR Gulf Valves 2025
Join this comprehensive session to explore the Myval transcatheter heart valve series, featuring the latest clinical updates from two large randomized controlled trials—Landmark and Compare TAVI. Learn from real-world experiences, including recorded cases, and understand how these innovations translate to complex patient demographics in daily TAVI...
PCR Gulf Valves 2025 Opening Ceremony
29 Sep 2025 – From PCR Gulf Valves 2025
Join us for the PCR Gulf Valves 2025 Opening Ceremony, marking the commencement of an exceptional congress dedicated to advances in structural heart interventions. This session sets the stage for the latest innovations and expert discussions that will shape the future of valve therapies in the...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
19 Dec 2024 – From GulfPCR-GIM 2024
Stay ahead in TAVI innovation by exploring the advanced balloon-expandable Myval THV series. This session highlights the latest clinical data, optimal sizing and implantation techniques, and valuable real-world insights, including long-term follow-up results.
TAVI in complex situation - LIVE case
18 Dec 2024 – From GulfPCR-GIM 2024
Discover a LIVE case followed by a recorded case exploring complex transcatheter aortic valve interventions:
- An 85-year-old woman with a history of RCA PCI, COPD, CKD stage 3, and LBBB on ECG presented with severe symptomatic aortic stenosis and preserved LV function (67%). With an aortic...
How to deal with PCI complications
18 Dec 2024 – From GulfPCR-GIM 2024
Interventional cardiology is not without its challenges. This session delves into the management of complex PCI complications, equipping you with the knowledge and techniques to prevent, recognize, and effectively handle life-threatening situations. From the dreaded 'no-flow' scenario to the most intricate perforations and massive thrombus burdens,...
GulfPCR-GIM 2024 Opening Ceremony
18 Dec 2024 – From GulfPCR-GIM 2024
The GulfPCR-GIM 2024 opening ceremony, live from Dubai, marks the start of this year’s premier interventional course in the Middle East. Building on the success of last year, which gathered over 1,100 participants and featured 50+ sessions, the 2024 edition promises an even richer program. Highlights...
Align for the future with Myval THV series and complex PCI solutions
18 Dec 2024 – From GulfPCR-GIM 2024
Explore the future of complex PCI with Meril Life’s advanced solutions. Learn about thin-strut platforms, dedicated stents for side branches and diffuse lesions, the role of drug-eluting balloons in metal-free PCI, and the clinical potential of the Myval THV technology.
